Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Biohaven Ltd. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 251
- −14 vs. Q1 2025
- Shares held
- 87.9M
- −3.48M (−3.8%) vs. Q1 2025
- Total value
- $1.24B
- −$1.00B (−44.7%) vs. Q1 2025
- New holders
- 38
- 98 more added
- Sold out
- 52
- 70 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 297 | $2.13B |
| Q1 2026 | 279 | $1.22B |
| Q4 2025 | 275 | $1.40B |
| Q3 2025 | 266 | $1.28B |
| Q2 2025 | 251 | $1.24B |
| Q1 2025 | 267 | $2.24B |
| Q4 2024 | 258 | $3.51B |
| Q3 2024 | 257 | $4.34B |
| Q2 2024 | 228 | $2.90B |
| Q1 2024 | 245 | $4.09B |
| Q4 2023 | 220 | $3.09B |
| Q3 2023 | 188 | $1.61B |
| Q2 2023 | 189 | $1.45B |
| Q1 2023 | 180 | $921.1M |
| Q4 2022 | 183 | $882.3M |
| Q3 2022 | 277 | $9.26B |
| Q2 2022 | 330 | $8.96B |
| Q1 2022 | 306 | $7.58B |
| Q4 2021 | 284 | $8.55B |
| Q3 2021 | 250 | $8.17B |
| Q2 2021 | 223 | $5.80B |
| Q1 2021 | 225 | $4.10B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Biohaven Ltd.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 300,000 | $4.23M | 0.07% | −260,056−46.4% | Reduced |
| Integral Health Asset Management, LLC | 300,000 | $4.23M | 0.40% | +125,000+71.4% | Added |
| Woodline Partners LP | 300,389 | $4.24M | 0.02% | −300,060−50.0% | Reduced |
| Emerald Advisers, LLC | 321,009 | $4.53M | 0.17% | −33,944−9.6% | Reduced |
| Citadel Advisors LLC | 323,351 | $4.56M | 0.00% | −904,022−73.7% | Reduced |
| Readystate Asset Management LP | 330,532 | $4.66M | 0.19% | +330,532 | New |
| QTR Family Wealth, LLC | 332,147 | $4.69M | 2.90% | −750.0% | Reduced |
| Barclays PLC | 347,163 | $4.90M | 0.00% | +183,545+112.2% | Added |
| Bank of America Corp | 420,501 | $5.93M | 0.00% | +49,417+13.3% | Added |
| Caption Management, LLC | 423,761 | $5.98M | 0.55% | +376,183+790.7% | Added |
| Nuveen, LLC | 445,660 | $6.29M | 0.00% | −466,918−51.2% | Reduced |
| 5AM Venture Management, LLC | 478,972 | $6.76M | 2.60% | 00.0% | Unchanged |
| Capital Research Global Investors | 484,193 | $6.83M | 0.00% | +484,193 | New |
| Pfizer Inc | 505,645 | $7.13M | 1.24% | 00.0% | Unchanged |
| Clearbridge Investments, LLC | 509,041 | $7.18M | 0.01% | −1,783−0.3% | Reduced |
| D. E. Shaw & Co., Inc. | 518,779 | $7.32M | 0.01% | +484,217+1,401.0% | Added |
| UBS Group AG | 529,821 | $7.48M | 0.00% | −107,052−16.8% | Reduced |
| Prosight Management, LP | 539,071 | $7.61M | 1.85% | +439,071+439.1% | Added |
| Infinitum Asset Management, LLC | 550,000 | $7.76M | 1.72% | +250,000+83.3% | Added |
| Fiera Capital Corp | 575,110 | $8.11M | 0.03% | −6,565−1.1% | Reduced |
| BNP Paribas Arbitrage, SA | 628,622 | $8.87M | 0.01% | +619,741+6,978.3% | Added |
| Adage Capital Partners GP, L.L.C. | 630,033 | $8.89M | 0.01% | +78,672+14.3% | Added |
| Cubist Systematic Strategies, LLC | 658,355 | $9.29M | 0.10% | +658,355 | New |
| American Century Companies Inc | 661,281 | $9.33M | 0.01% | +94,780+16.7% | Added |
| Oracle Investment Management Inc | 673,166 | $9.50M | 8.22% | +7,221+1.1% | Added |
| Logos Global Management LP | 700,000 | $9.88M | 1.32% | +700,000 | New |
| UBS Asset Management Americas Inc | 703,309 | $9.92M | 0.00% | +113,694+19.3% | Added |
| Charles Schwab Investment Management Inc | 712,055 | $10.0M | 0.00% | +24,554+3.6% | Added |
| Redmile Group, LLC | 729,515 | $10.3M | 1.10% | −137,939−15.9% | Reduced |
| Morgan Stanley | 737,676 | $10.4M | 0.00% | −221,237−23.1% | Reduced |
| Northern Trust Corp | 776,495 | $11.0M | 0.00% | −24,093−3.0% | Reduced |
| Knoll Capital Management, LLC | 895,269 | $12.6M | 8.98% | +64,390+7.7% | Added |
| Norges Bank | 902,565 | $12.7M | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 979,917 | $13.8M | 0.00% | +175,991+21.9% | Added |
| Brown Advisory Inc | 1,121,744 | $15.8M | 0.02% | +101,627+10.0% | Added |
| ARS Investment Partners, LLC | 1,188,126 | $16.8M | 1.22% | +148,255+14.3% | Added |
| Voloridge Investment Management, LLC | 1,439,120 | $20.3M | 0.07% | +1,292,321+880.3% | Added |
| Holocene Advisors, LP | 1,495,641 | $21.1M | 0.05% | +239,889+19.1% | Added |
| Millennium Management LLC | 1,627,539 | $23.0M | 0.02% | +726,281+80.6% | Added |
| FMR LLC | 1,664,913 | $23.5M | 0.00% | −246,357−12.9% | Reduced |
| Geode Capital Management, LLC | 2,030,919 | $28.7M | 0.00% | +71,939+3.7% | Added |
| Armistice Capital, LLC | 2,136,000 | $30.1M | 1.14% | +462,578+27.6% | Added |
| JPMorgan Chase & Co | 2,572,042 | $36.3M | 0.00% | +612,209+31.2% | Added |
| Bellevue Group AG | 2,802,853 | $39.5M | 0.87% | +762,000+37.3% | Added |
| Price T Rowe Associates Inc | 3,171,235 | $44.7M | 0.01% | +348,261+12.3% | Added |
| State Street Corp | 3,538,163 | $49.9M | 0.00% | +115,814+3.4% | Added |
| Janus Henderson Group PLC | 5,053,528 | $71.3M | 0.03% | −1,384,701−21.5% | Reduced |
| Suvretta Capital Management, LLC | 5,620,271 | $79.3M | 2.99% | 00.0% | Unchanged |
| Stifel Financial Corp | 6,607,511 | $93.2M | 0.09% | +1,8990.0% | Added |
| BlackRock, Inc. | 7,535,273 | $106.3M | 0.00% | +52,418+0.7% | Added |
| Vanguard Group Inc | 9,249,597 | $130.5M | 0.00% | +828,805+9.8% | Added |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −4,813,167−100.0% | Sold out |
| RP Management, LLC | 0 | $0 | 0.00% | −2,936,507−100.0% | Sold out |
| Capital International Investors | 0 | $0 | 0.00% | −671,414−100.0% | Sold out |
| Boone Capital Management LLC | 0 | $0 | 0.00% | −270,198−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −197,307−100.0% | Sold out |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −153,825−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −109,052−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −106,351−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −94,424−100.0% | Sold out |
| EFG Asset Management (North America) Corp. | 0 | $0 | 0.00% | −90,264−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −87,367−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −77,102−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −61,572−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −54,447−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −42,077−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −39,900−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −37,446−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −31,400−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −31,356−100.0% | Sold out |
| VELA Investment Management, LLC | 0 | $0 | 0.00% | −26,836−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −18,741−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −15,011−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −14,394−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −12,923−100.0% | Sold out |
| Adviser Investments LLC | 0 | $0 | 0.00% | −12,622−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −11,284−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,321−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0 | $0 | 0.00% | −9,463−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −8,897−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −8,835−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −8,825−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −3,418−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,167−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −1,055−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −814−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −290−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Tidemark, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |